Exon Genetic & Biotechnology Engages Uganda’s Leadership on New Investments Exon Genetic & Biotechnology and BEYLER GROUP have maintained a strong interest in Uganda as part of their wider healthcare and investment activities in East Africa. On May 25, 2022, Uganda President H.E. Yoweri Kaguta Museveni received BEYLER GROUP Chairman
Strengthening Healthcare and Investment Cooperation in Uganda Exon Genetic & Biotechnology has maintained an active interest in Uganda as part of its wider African healthcare and investment strategy. In a February 2020 report, the company described a Uganda business trip organized by BEYLER GROUP in which companies from Türkiye participated.
